Contribution of peptides to multiple sclerosis research

Biopolymers
Maria Claudia Alcaro, Anna Maria Papini

Abstract

Multiple sclerosis (MS) is an autoimmune disease associated with chronic inflammatory demyelination of the central nervous system in genetically susceptible individuals. Because of the disease complexity and heterogeneity, its pathogenesis remains unknown despite extensive research efforts, and specific effective treatments have not yet been developed. Peptide-based research has been important in attempts to unravel particular aspects of this complex disease, including the characterization of the different molecular mechanisms of MS, with the goal of providing useful products for immune-mediated therapies. In fact, in the past decade, peptide-based research has been predominant in research aimed to identify and/or develop target antigens as synthetic probes for specific biomarkers as well as innovative immunomodulating therapies. This review presents an overview of the contributions of peptide science to MS research and discusses future directions of peptide-based investigations.

References

Jan 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·D TeitelbaumM Sela
Aug 1, 1991·Immunology Today·K W WucherpfennigD A Hafler
Nov 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·D TeitelbaumR Arnon
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D TeitelbaumM Sela
Nov 1, 1995·Journal of the Neurological Sciences·K G Warren, I Catz
Feb 15, 1996·Journal of Neuroscience Research·A A VandenbarkH Offner
Jan 1, 1996·Annual Review of Immunology·J Sloan-Lancaster, P M Allen
Oct 1, 1996·Nature Medicine·J P AntelT Owens
Sep 1, 1996·The Journal of Experimental Medicine·C KurtsH Kosaka
Apr 1, 1996·Multiple Sclerosis : Clinical and Laboratory Research·C M PelfreyH F McFarland
Apr 9, 1998·Multiple Sclerosis : Clinical and Laboratory Research·I CorteseR Cortese
May 23, 1998·Annual Review of Immunology·M M DavisY Chien
Aug 14, 1998·Nature Biotechnology·G GrassyR Buelow
Oct 23, 1998·The Journal of Experimental Medicine·K J SmithK W Wucherpfennig
Nov 6, 1998·The Journal of Experimental Medicine·R L Ufret-VincentyS Brocke
Apr 20, 1999·The Journal of Experimental Medicine·P J RuizL Steinman
Jun 23, 1999·Proceedings of the National Academy of Sciences of the United States of America·O RötzschkeJ L Strominger

❮ Previous
Next ❯

Citations

Jun 26, 2012·Journal of Autoimmunity·Nicolas SchallSylviane Muller
Jun 23, 2007·Neuropharmacology·Abbas Mirshafiey
May 10, 2015·Expert Opinion on Therapeutic Patents·Anna Maria Papini, Enrico König
Mar 18, 2010·Immunopharmacology and Immunotoxicology·Abbas Mirshafiey, Farhad Jadidi-Niaragh
Mar 20, 2010·Immunopharmacology and Immunotoxicology·Abbas Mirshafiey, Farhad Jadidi-Niaragh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.